In other studies, Zhao et al (2004) showed that MMP-26 is important in the activation of MMP-9 in breast carcinomas, where its activity is inhibited by TIMPs-2 and -4, suggesting that the interplay between these factors may be a significant determinant of malignancy in both breast and prostate neoplasia. The gene discussed is MMP9; the disease is breast carcinoma.